Santa Cruz Biotechnology

UBP 282-2 | Santa Cruz Biotechnology

GluR Inhibitor, UBP 282 is a receptor antagonist that distinguishes between motoneuron and dorsal root kainate receptors

Reviews


No reviews yet

ABOUT THE COMPANY

Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past 30+ years, the Company has focused on the ongoing development of research antibodies, siRNA and CRISPR Gene editing tools, biochemicals, labware and more recently has expanded into animal health care products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.